Veterinary Guide - Bio Pathica Ltd

Lymphomyosot N drops: 100 g cont.: Myosotis arvensis D3, Veronica officinalis D3,
Teucrium scorodonia D3, Pinus sylvestris D4, Gentiana lutea D5, Equisetum hyemale
D4, Smilax D6, Scrophularia nodosa D3, Calcium phosphoricum D12, Natrium sulfuricum
D4, Fumaria officinalis D4, Levothyroxinum D12, Araneus diadematus D6 5 g
each; Geranium robertianum D4, Nasturtium officinale D4, Ferrum jodatum D12 10 g
each. Contains 35 vol.-% alcohol.
Indications:
Lymphatism (tendency to hypertrophy of the lymphatic organs, tendency to formation
of edemas and to susceptability to infection); glandular swelling; tonsillar hypertrophy
and chronic tonsillitis.
Contraindications: Do not use in thyroid conditions without seeking medical advise.
Side effects: (Injection solution) Hypersensitivity reactions (or even anaphylactic reactions)
may occur in isolated instances on the i.v. administration of foreign proteins in a
concentration higher than D10.
Interaction with other medications: None known.
Dosage:
See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.
Package sizes:
Lymphomyosot N injection solution: Packs containing 10 or 50 ampoules of 1.1 ml
each.
Lymphomyosot N drops: Drop bottles containing 30 or 100 ml.
Mercurius-Heel ® S Tablets
Composition:
1 tablet cont.: Mercurius solubilis Hahnemanni D10 90 mg; Hepar sulfuris D8, Lachesis
mutus D12, Phytolacca americana D4, Ailanthus altissima D3, Echinacea angustifolia
D3 30 mg each; Atropa belladonna D4 60 mg.
Indications:
Furuncles, carbuncles and other suppurations, including, e.g. those in the (peri)-tonsillar
tissue.
Contraindications: Hypersensitivity to one of the active ingredients or excipients, or to
plants of the composite family. As a matter of principle, Echinacea should not be used
in progressive, systemic diseases such as tuberculosis, leukemia or leukemia-like diseases,
inflammatory diseases of the connective tissue (collagen disease), autoimmune
diseases, multiple sclerosis, AIDS, HIV infections or other chronic viral diseases.
Side effects: Hypersalivation may occur after administration, in which case the use of
this product should be discontinued. Hypersensitivity reactions can occur in individual
cases. Skin rash and itching (pruritus), and in rare cases facial swelling, shortness of
breath (dyspnea), dizziness and a fall in blood pressure, have been observed after
treatment with products containing Echinacea extracts. Allergic reactions may occasionally
occur on account of the homeopathic active substance Mercurius solubilis,
too.
Interaction with other medications: None known.
Dosage:
See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.
Package sizes:
Packs containing 50 and 250 tablets.
Mucosa compositum ad us. vet. Injection Solution 5.0 ml
Mucosa compositum Heel Injection Solution 2.2 ml
Composition:
Mucosa compositum ad us. vet.: 1 ampoule of 5.0 ml contains: Mucosa nasalis suis D8;
Mucosa oris suis D8; Mucosa pulmonis suis D8; Mucosa oculi suis D8; Mucosa vesicae
felleae suis D8; Mucosa pylori suis D8; Mucosa duodeni suis D8; Mucosa oesophagi
suis D8; Mucosa jejuni suis D8; Mucosa ilei suis D8; Mucosa coli suis D8; Mucosa recti
suis D8; Mucosa ductus choledochi suis D8; Mucosa vesicae urinariae suis D8; Ventriculus
suis D8; Pankreas suis D10; Argentum nitricum D6; Atropa belladonna D10;
Oxalis acetosella D6; Semecarpus anacardium D6; Phosphorus D8; Lachesis mutus
D10; Ipecacuanha D8; Nux vomica D13; Veratrum album D4; Pulsatilla pratensis D6;
Kreosotum D10; Sulfur D8; Bacterium coli-Nosode D28; Marsdenia cundurango D6;
Kalium bichromicum D8; Hydrastis canadensis D4; Mandragora e radice siccato D10;
Momordica balsamina D6; Ceanothus americanus D4; Natrium diethyloxalaceticum D8
0.05 ml each.
102 103